Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Maria Greenwald, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 24, pp. 2295-2306
Open Access | Times Cited: 376

Showing 51-75 of 376 citing articles:

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
Philip J. Mease, Philip Helliwell, Kasper Fjellhaugen Hjuler, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 2, pp. 185-193
Open Access | Times Cited: 108
Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
Agnieszka Wasilewska, Marta Winiarska, Małgorzata Olszewska, et al.
Advances in Dermatology and Allergology (2016) Vol. 4, pp. 247-252
Open Access | Times Cited: 106
Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
Jennifer Belasco, James S. Louie, Nicholas Gulati, et al.
Arthritis & Rheumatology (2014) Vol. 67, Iss. 4, pp. 934-944
Open Access | Times Cited: 104
Enthesitis: Much More Than Focal Insertion Point Inflammation
‬‬‬‬Abdulla Watad, Richard Cuthbert, Howard Amital, et al.
Current Rheumatology Reports (2018) Vol. 20, Iss. 7
Open Access | Times Cited: 104
Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma
Patrick Mitchell, Paul M. O’Byrne
Pharmacology & Therapeutics (2016) Vol. 169, pp. 104-112
Closed Access | Times Cited: 103
Interleukin‐17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
James G. Krueger, Patrick M. Brunner
Experimental Dermatology (2017) Vol. 27, Iss. 2, pp. 115-123
Open Access | Times Cited: 99
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18
James L. Wynn, Chris S. Wilson, Jacek Hawiger, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 19
Open Access | Times Cited: 97
Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis
Brian Astry, Shivaprasad H. Venkatesha, Kamal D. Moudgil
Cytokine (2015) Vol. 74, Iss. 1, pp. 54-61
Open Access | Times Cited: 95
Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?
Ian R. Barrows, Ali Ramezani, Dominic S. Raj
Advances in Chronic Kidney Disease (2019) Vol. 26, Iss. 2, pp. 122-130
Open Access | Times Cited: 93
Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
Sumit Kunwar, Khagendra Dahal, Sharan Prakash Sharma
Rheumatology International (2016) Vol. 36, Iss. 8, pp. 1065-1075
Closed Access | Times Cited: 89
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, Lucía Tejedor-Santamaria, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 83
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Hiroyuki Tsukazaki, Takashi Kaito
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6401-6401
Open Access | Times Cited: 82
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Yunjuan Nie, Shuohua Wu, Ying-Hua Xuan, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 61
The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
Feliciano Chanana Paquissi, Hugo Abensur
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 60
Pathogenesis, multi-omics research, and clinical treatment of psoriasis
Jiadong Yu, Qixiang Zhao, Xiaoyan Wang, et al.
Journal of Autoimmunity (2022) Vol. 133, pp. 102916-102916
Closed Access | Times Cited: 53
Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes
Iain B. McInnes, L. Sawyer, Kristen Markus, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002074-e002074
Open Access | Times Cited: 48
Role of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases
Saima Akhter, Farhin Muntaha Tasnim, Mohammad Nazmul Islam, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 26, pp. 2078-2090
Closed Access | Times Cited: 28
Interactions between neutrophils and T-helper 17 cells
Xinzou Fan, Panyin Shu, Ying Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Immunological factors, important players in the development of asthma
Yang Wang, Li Liu
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 12
Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
Shivaprasad H. Venkatesha, Steven Dudics, Bodhraj Acharya, et al.
International Journal of Molecular Sciences (2014) Vol. 16, Iss. 1, pp. 887-906
Open Access | Times Cited: 92
IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice
Jau‐Yi Li, Patrizia D’Amelio, Jerid W. Robinson, et al.
Cell Metabolism (2015) Vol. 22, Iss. 5, pp. 799-810
Open Access | Times Cited: 90
New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
Jacek Karczewski, Agnieszka Dobrowolska, Anna Rychlewska-Hańczewska, et al.
Autoimmunity (2016) Vol. 49, Iss. 7, pp. 435-450
Closed Access | Times Cited: 85
Switching biologics in the treatment of psoriatic arthritis
Joseph F. Merola, Benjamin Lockshin, Elinor Mody
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 1, pp. 29-37
Open Access | Times Cited: 83
Phase II Study of ABT‐122, a Tumor Necrosis Factor– and Interleukin‐17A–Targeted Dual Variable Domain Immunoglobulin, in Patients With Psoriatic Arthritis With an Inadequate Response to Methotrexate
Philip J. Mease, Mark C. Genovese, Michael E. Weinblatt, et al.
Arthritis & Rheumatology (2018) Vol. 70, Iss. 11, pp. 1778-1789
Open Access | Times Cited: 82
Anti-IL17 therapies for psoriasis
Annika Silfvast‐Kaiser, So Yeon Paek, Alan Menter
Expert Opinion on Biological Therapy (2018) Vol. 19, Iss. 1, pp. 45-54
Closed Access | Times Cited: 82

Scroll to top